{"id":"https://genegraph.clinicalgenome.org/r/57cd4d37-83ba-4ba1-bdf5-fa70840e4508v1.0","type":"EvidenceStrengthAssertion","dc:description":"There has been sufficient amount of evidence published associating the PTCH1 gene with nevoid basal cell carcinoma syndrome (Gorlin syndrome) since the gene-disease relationship was first proposed by Johnson et al. (1996). Plenty of case level studies have been performed with BCC patients that have variants in the PTCH1 gene. Multiple PTCH1 deficient mouse models have been established to show consistent phenotypes with NBCCS patients. Untreated Ptch+/– mice have microscopic skin tumors. UV and ionizing radiation enhances BCC tumorigenesis in Ptch+/– mouse. All of these types of evidence suggest a definitive relationship between the PTCH1 gene and nevoid basal cell carcinoma syndrome (Gorlin syndrome).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/57cd4d37-83ba-4ba1-bdf5-fa70840e4508","GCISnapshot":"https://genegraph.clinicalgenome.org/r/2a3f55f5-e39b-4571-a41f-e46ddb8e298d","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/2a3f55f5-e39b-4571-a41f-e46ddb8e298d_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2020-09-01T00:00:00Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/2a3f55f5-e39b-4571-a41f-e46ddb8e298d_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2018-06-04T17:00:00.000Z","role":"Approver"}],"curationReasonDescription":"","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2a3f55f5-e39b-4571-a41f-e46ddb8e298d_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2a3f55f5-e39b-4571-a41f-e46ddb8e298d_ad_dn_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/34125ea7-ec8f-4f2d-9313-92a5e785bbd6_proband_score_evidence_line","type":"EvidenceLine","dc:description":"They detected an SSCP alteration in her DNA that is not present in DNA from her unaffected parents, who have the same SSCP pattern as 84 other control chromosomes.  The resulting frameshift truncates the ORF by creating a stop codon nine amino acids after amino acid 813, just after the putative seventh transmembrane domain.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/49e8f00e-af9d-4566-b97e-1b247811fd85","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8658145","rdfs:label":"18-year-old woman","ageType":"AgeAtReport","ageUnit":"Years","ageValue":18,"detectionMethod":"Single-strand conformation polymorphism (SSCP) analysis of PCR-amplified DNA from normal individuals, BCNS patients, and sporadic BCCs was performed for 20 exons of PTC coding sequence","firstTestingMethod":"PCR","phenotypeFreeText":"ORPHA:377, Gorlin syndrome","phenotypes":"obo:HP_0002671","previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/34125ea7-ec8f-4f2d-9313-92a5e785bbd6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8658145","allele":{"id":"https://genegraph.clinicalgenome.org/r/f5ce8f05-0ffe-47c1-a974-30107f00dddf","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"PTCH1, 11-BP DEL, NT2442","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/8212"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes"}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/9f95d092-182e-435c-9757-74f31ff17272_proband_score_evidence_line","type":"EvidenceLine","dc:description":"a germline 1-bp insertion (2000insC) in exon 13 lead to frameshift. Both parents of the patient lacked the mutation and were free of phenotypic features of NBCCS.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f928aa9f-43c6-4cac-93e7-29a55301d980","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8681379","rdfs:label":"2000insC","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","firstTestingMethod":"PCR","phenotypeFreeText":"ORPHA:377, Gorlin syndrome","phenotypes":"obo:HP_0002671","previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/9f95d092-182e-435c-9757-74f31ff17272_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8681379","allele":{"id":"https://genegraph.clinicalgenome.org/r/9aec57ea-ad97-453e-8bb0-22658edc441e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"PTCH1, 1-BP INS, 2000C","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/8217"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallAutosomalDominantDeNovoVariantEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/2a3f55f5-e39b-4571-a41f-e46ddb8e298d_ad_null_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/71544f6a-26dd-4ab4-b3fa-28a2a2886ba5_proband_score_evidence_line","type":"EvidenceLine","dc:description":"a premature stop codon in exon 8","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/eca4b82f-ed4b-4f62-8541-03bab4bd9a9a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8681379","rdfs:label":"G1148A","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","firstTestingMethod":"PCR","phenotypeFreeText":"ORPHA:377, Gorlin syndrome","phenotypes":"obo:HP_0002671","previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/71544f6a-26dd-4ab4-b3fa-28a2a2886ba5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8681379","allele":{"id":"https://genegraph.clinicalgenome.org/r/3cdaaea6-2908-43cf-8bc5-6bb4d0ce2162","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"PTCH1, 1148G-A","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/8215"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/c4b6df5a-6550-47a5-9a3c-caff06ac1146_proband_score_evidence_line","type":"EvidenceLine","dc:description":"a 1-bp insertion (T) at nucleotide 1247 in exon 9 of the PTCH1 gene, resulting in premature termination of the protein.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9c09df77-03a3-46b0-8cab-8720911f33f9","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12900905","rdfs:label":"a 14-year-old Japanese girl","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":14,"detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypeFreeText":"ORPHA:377, Gorlin syndrome","phenotypes":["obo:HP_0100279","obo:HP_0002650","obo:HP_0002671"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/c4b6df5a-6550-47a5-9a3c-caff06ac1146_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12900905","allele":{"id":"https://genegraph.clinicalgenome.org/r/2f14de82-e117-45e2-9c27-13ba6c0e784c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"PTCH1, 1-BP INS, 1247T","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/8226"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/efd864b2-1cbb-4c3b-a376-63bff41678ad_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Premature stop in exon 8","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e7880cd5-e508-44c3-b91a-a1b7b656557b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8681379","rdfs:label":"C1081T","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","firstTestingMethod":"PCR","phenotypeFreeText":"ORPHA:377, Gorlin syndrome","phenotypes":"obo:HP_0002671","previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/efd864b2-1cbb-4c3b-a376-63bff41678ad_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8681379","allele":{"id":"https://genegraph.clinicalgenome.org/r/c009d21a-f3e8-4d89-a6c5-49efb8642632","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001083602.2(PTCH1):c.895C>T (p.Gln299Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/156352"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/f7049cdb-74ff-4471-8c06-d823aee833eb_proband_score_evidence_line","type":"EvidenceLine","dc:description":"a 2-bp insertion at nucleotide 2047 (2047insCT) in exon 13 lead to frameshift","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a5ce3450-1222-4a6d-ac86-10ecea8687db","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8681379","rdfs:label":"2047insCT","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","firstTestingMethod":"PCR","phenotypeFreeText":"ORPHA:377, Gorlin syndrome","phenotypes":"obo:HP_0002671","previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/f7049cdb-74ff-4471-8c06-d823aee833eb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8681379","allele":{"id":"https://genegraph.clinicalgenome.org/r/2ec33832-4252-41e0-bab9-5fd45600c0fd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"PTCH1, 2-BP INS, 2047CT","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/8216"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/a1d10d68-292f-4701-ae57-5c0f79cae689_proband_score_evidence_line","type":"EvidenceLine","dc:description":"a 37-bp deletion (del 808-840) in exon 6 lead to frameshift","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3461f70b-4f11-470b-ad1b-bb32b67babbf","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8681379","rdfs:label":"del 804-840","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","firstTestingMethod":"PCR","phenotypeFreeText":"ORPHA:377, Gorlin syndrome","phenotypes":"obo:HP_0002671","previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/a1d10d68-292f-4701-ae57-5c0f79cae689_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8681379","allele":{"id":"https://genegraph.clinicalgenome.org/r/f4d2f271-670a-42f2-9b7d-00ead87b0d01","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"PTCH1, 37-BP DEL, NT808","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/8214"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/2dd0ed1b-eea7-4892-90b1-a8c7fb70cc11_proband_score_evidence_line","type":"EvidenceLine","dc:description":"a germline 1-bp deletion (2583delC) in exon 15 lead to frameshift","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3d0fb814-6cb6-4591-9ce5-be46d1f820d9","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8681379","rdfs:label":"2583delC","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","firstTestingMethod":"PCR","phenotypeFreeText":"ORPHA:377, Gorlin syndrome","phenotypes":"obo:HP_0002671","previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/2dd0ed1b-eea7-4892-90b1-a8c7fb70cc11_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8681379","allele":{"id":"https://genegraph.clinicalgenome.org/r/f3db9410-b174-48b3-a253-eb9dd236e657","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"PTCH1, 1-BP DEL, 2583C","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/8218"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallAutosomalDominantNullVariantEvidenceCriteria","strengthScore":9},{"id":"https://genegraph.clinicalgenome.org/r/2a3f55f5-e39b-4571-a41f-e46ddb8e298d_ad_other_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e84be9d2-2dd3-4e09-88dc-da710af9e934_proband_score_evidence_line","type":"EvidenceLine","dc:description":"The author didn't provide any functional evidence for this three amino acids insertion variant.  But there is another single amino acid deletion variant (Q816del) at the same location that are reported with the same disease (PMID: 8840969).  This indicates the possible importance of this location for protein function.  Reduce point to 0.25.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8289f92b-65c6-489c-8b47-42bdd05a2c22","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8658145","rdfs:label":"II-2","ageType":"AgeAtReport","ageUnit":"Years","ageValue":49,"detectionMethod":"Single-strand conformation polymorphism (SSCP) analysis of PCR-amplified DNA from normal individuals, BCNS patients, and sporadic BCCs was performed for 20 exons of PTC coding sequence","firstTestingMethod":"PCR","phenotypeFreeText":"ORPHA:377, Gorlin syndrome","phenotypes":"obo:HP_0002671","previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/e84be9d2-2dd3-4e09-88dc-da710af9e934_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8658145","allele":{"id":"https://genegraph.clinicalgenome.org/r/e6684e9d-a7b8-43fc-b160-8908239bbf88","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"PTCH1, 9-BP INS, CODON 815, PRO-ASN-ILE INS","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/8211"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.25}],"specifiedBy":"GeneValidityOverallAutosomalDominantOtherVariantEvidenceCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/2a3f55f5-e39b-4571-a41f-e46ddb8e298d_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/54fef5c4-d72e-4850-b67d-3d209fe4b887_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8658145","rdfs:label":"49-year-old affected man","estimatedLodScore":0.9,"family":{"id":"https://genegraph.clinicalgenome.org/r/54fef5c4-d72e-4850-b67d-3d209fe4b887","type":"Family","rdfs:label":"49-year-old affected man","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/8289f92b-65c6-489c-8b47-42bdd05a2c22"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"ORPHA:377, Gorlin syndrome","phenotypePositiveAllelePositive":4,"phenotypes":"obo:HP_0002671","proband":{"id":"https://genegraph.clinicalgenome.org/r/8289f92b-65c6-489c-8b47-42bdd05a2c22"}},{"id":"https://genegraph.clinicalgenome.org/r/4ac8df7b-0133-4aa8-8b3d-a0a909ae13cb_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8658145","rdfs:label":"18-year-old woman","family":{"id":"https://genegraph.clinicalgenome.org/r/4ac8df7b-0133-4aa8-8b3d-a0a909ae13cb","type":"Family","rdfs:label":"18-year-old woman","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/49e8f00e-af9d-4566-b97e-1b247811fd85"}},"phenotypeFreeText":"ORPHA:377, Gorlin syndrome","phenotypePositiveAllelePositive":1,"phenotypes":"obo:HP_0002671","proband":{"id":"https://genegraph.clinicalgenome.org/r/49e8f00e-af9d-4566-b97e-1b247811fd85"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/2a3f55f5-e39b-4571-a41f-e46ddb8e298d_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2a3f55f5-e39b-4571-a41f-e46ddb8e298d_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/185a3c7d-bdb8-416d-be25-e8b0beccdbe0","type":"EvidenceLine","dc:description":"Only showed the similarities in the retinal abnormalities between BCNS patients and PtchlacZ +/-􏰀 mice but not other phenotypes.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4ef77490-cb6b-483f-b1c8-d4d75f75e78e","type":"Finding","dc:description":"9/30 patients had early-onset unilateral visual reduction as a direct result of a structural ocular abnormality that could be attributed to BCNS. Retinal and vitreoretinal abnormalities in 11/30 patients. \nRetinal dysplasia and gliosis associated with Ptch mutation in mice.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14570707","rdfs:label":"Retinal abnormalities similar between BCNS patient and mice","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/05e0cb27-58ca-4f04-8cbe-33029d6b21ca","type":"EvidenceLine","dc:description":"The authors speculated that their failure to observe basal cell carcinomas in the heterozygous mice may have been because somatic inactivation of the second ptc gene is required as it is in human basal cell carcinomas.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/047d8c69-ba3d-4192-a19a-d2dedad87105","type":"Finding","dc:description":"Mice heterozygous for the ptch mutation were larger than normal, and a subset of them developed hindlimb defects (including extra digits, syndactyly and soft tissue tumors) or cerebellar medulloblastomas, abnormalities also seen in patients with the basal cell nevus syndrome.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9262482","rdfs:label":"The ptc+/- mice had features in common with BCNS patients","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/d9a9bce0-7ba9-487d-ba98-a19bb0c01b70","type":"EvidenceLine","dc:description":"The Ptch mutant mice provide the mouse model of ultraviolet and ionizing radiation-induced basal cell carcinoma-like tumors, and also demonstrate that Ptch inactivation and hedgehog target gene activation are essential for basal cell carcinoma tumorigenesis.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a524f013-8c48-4f39-a7ce-661baed43198","type":"Finding","dc:description":"Untreated Ptch+/– mice have microscopic skin tumors. UV and ionizing radiation enhances BCC tumorigenesis in Ptch +/– mouse. Histology resembles human trichoblastomas and BCCs. Mouse and human BCCs have similar immunohistology. Mouse tumors have Ptch loss of heterozygosity.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10545995","rdfs:label":"UV enhances BCC tumorigenesis in Ptch +/– mouse","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/f4443df4-b960-419e-9a10-ac7073e3b248","type":"EvidenceLine","dc:description":"Only showed the involvement of Ptch1 in bone formation and postnatal bone homeostasis but not other phenotypes.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8988007d-be65-4c7e-a892-77db0fb48d98","type":"Finding","dc:description":"The serum level of bone-specific ALP and the urine level of deoxypyridinolines of the male patient were markedly elevated (Table S1), suggesting increased bone metabolism. This finding in NBCCS patients is consistent with the phenotypes observed in Ptch1+/\u0002- mice.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18477452","rdfs:label":"Ptch1+/- mice and patients with NBCCS showed high bone mass","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/2a3f55f5-e39b-4571-a41f-e46ddb8e298d_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ab8cfaa7-c04c-4ddf-8310-efb764cbbc38","type":"EvidenceLine","dc:description":"PTCH1 and PTCH2 are two patched receptors functioning in hh signaling. Mutations in PTCH2 can cause Gorlin-like phenotype (odontogenic cysts, etc) with milder phenotype and lower penetrance than the PTCH1-associated genotype.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9e2ca39f-aaa1-45b3-bfe9-60c0ae4dd6c2","type":"Finding","dc:description":"Binding analysis shows that both PTCH1 and PTCH2 can interact with all HH family members with similar affinity, and form a complex with SMO.  Suppression of hair-follicle development inhibits induction of Shh, Ptch1 and Ptch2 in hair germs in mice. Loss of Ptch2 markedly promotes tumour formation in combination with Ptch1 haploinsufficiency.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18285427","rdfs:label":"PTCH2 also cause dominantly inherited NBCCS","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/bd0da47a-c73b-441a-afac-c1099f7b7e29","type":"EvidenceLine","dc:description":"SUFU-related NBCCS is associated with a high risk for medulloblastoma of up to 33% (3/9) and a high meningioma risk post radiation.\nFacial features are likely more subtle in individuals with an SUFU pathogenic variant.\nOverall, clinical features are milder in individuals with SUFU-related NBCCS with less BCCs, and no jaw cysts reported [Evans et al 2017].","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/751f12a3-4633-421a-9322-3280e5be0b15","type":"Finding","dc:description":"PTCH1 acts as a receptor for hh signaling.  SUFU is a negative regulator of SHH signaling that interacts with all three GLI proteins and mediates their nuclear export in the absence of SHH [Dunaeva et al., 2003].","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19533801","rdfs:label":"SUFU, a negative regulator in hh signaling related to NBCCS","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":5}],"evidenceStrength":"Definitive","sequence":142,"specifiedBy":"GeneValidityCriteria5","strengthScore":17,"subject":{"id":"https://genegraph.clinicalgenome.org/r/KI19A2B4kno","type":"GeneValidityProposition","disease":"obo:MONDO_0007187","gene":"hgnc:9585","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_2a3f55f5-e39b-4571-a41f-e46ddb8e298d-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}